πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 7 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11279703

Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

APTOSE BIOSCIENCES INC. Β· Granted Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11149047

Aryl imidazoles for treatment of cancer

APTOSE BIOSCIENCES INC. Β· Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11104957

Compositions and methods for treating cancers

APTOSE BIOSCIENCES INC. Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10080739

Aryl imidazoles and their use as anti-cancer agents

APTOSE BIOSCIENCES INC. Β· Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9567643

Compositions and methods for treating cancers

APTOSE BIOSCIENCES INC. Β· Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8987305

2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

APTOSE BIOSCIENCES INC. Β· Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8969372

Aryl imidazoles and their use as anti-cancer agents

Aptose Boisciences Inc. Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted